WELLESLEY PHARMACEUTICALS LLC — Form D/A
WELLESLEY PHARMACEUTICALS LLC of NEWTOWN, PA, a company, filed a Form D amendment with the SEC on 2017-10-13. The offering totals $5.8M, of which $3.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-10-13
- Form: D/A
- Accession: 0001634861-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.8M
- Amount sold: $3.8M
- Remaining: $2.0M
- Investors: 14
- Date of first sale: 2015-03-28
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-261698
Issuer
- Name: WELLESLEY PHARMACEUTICALS LLC
- CIK: 0001634861
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 3 VALLEY VIEW DRIVE, NEWTOWN, PA, 18940
- Phone: 2154930168
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Alan Dill | Director | Newtown, PA |
| Candan Alan Karabagli | Director | Newtown, PA |
| Omer Alan Karahan | Director | Newtown, PA |
| Christopher Alan Lineberry | Director | Bolton, MA |
| David Alan Dill | Executive Officer | Newtown, PA |
Other filings by this issuer (3)
More